OBJECTIVE: 1) To describe a patient with rheumatoid arthritis receiving adalimumab who developed fever, pancytopenia, splenomegaly, and extreme hyperferritinemia.
splenomegaly
adalimumab
fever
adalimumab
pancytopenia
adalimumab
extreme hyperferritinemia
adalimumab